1. Home
  2. CYD vs VIR Comparison

CYD vs VIR Comparison

Compare CYD & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo China Yuchai International Limited

CYD

China Yuchai International Limited

HOLD

Current Price

$40.53

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

HOLD

Current Price

$11.27

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CYD
VIR
Founded
1951
2016
Country
Singapore
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
CYD
VIR
Price
$40.53
$11.27
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$60.00
$19.43
AVG Volume (30 Days)
108.5K
1.5M
Earning Date
02-24-2026
05-06-2026
Dividend Yield
1.32%
N/A
EPS Growth
N/A
17.49
EPS
N/A
N/A
Revenue
N/A
$68,556,000.00
Revenue This Year
$15.11
$270.22
Revenue Next Year
$8.67
N/A
P/E Ratio
$32.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$28.65
$4.75
52 Week High
$61.48
$11.66

Technical Indicators

Market Signals
Indicator
CYD
VIR
Relative Strength Index (RSI) 38.62 73.93
Support Level $37.24 $8.43
Resistance Level $45.94 $11.66
Average True Range (ATR) 1.84 0.51
MACD -0.59 0.25
Stochastic Oscillator 28.79 93.86

Price Performance

Historical Comparison
CYD
VIR

About CYD China Yuchai International Limited

China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: